查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1984150

生物防治剂市场：2026-2032年全球市场预测（依产品类型、作物类型、製剂形式、应用方法、通路和最终用户划分）

Biological Control Agents Market by Product Type, Crop Type, Formulation, Mode Of Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物害虫防治市场价值将达到 61.2 亿美元，到 2026 年将成长至 65.9 亿美元，年复合成长率为 7.74%，到 2032 年将达到 103.2 亿美元。

主要市场统计数据
基准年 2025 61.2亿美元
预计年份：2026年 65.9亿美元
预测年份 2032 103.2亿美元
复合年增长率 (%) 7.74%

为引入生物防治提供了一个背景框架，阐明了影响整个作物保护组合策略决策的监管、农业化学品和商业性驱动因素。

随着相关人员寻求永续的、生物防治的替代传统化学防治方法，农业格局正在经历根本性的变革。对合成农药日益严格的监管、消费者对无残留农产品的需求不断增长，以及对具有韧性的供应链日益迫切的需求，共同推动了生物防治从一项小众创新发展成为一项战略重点。本文阐述了生物防治（包括信息素、植物萃取物、活体大型生物和微生物製剂）如何融入更广泛的作物保护方案，以及它如何影响长期的农业化学品策略。

科学进步、监管改进和不断发展的商业管道如何改变生物害虫防治的引入途径和竞争动态。

生物防治剂领域的格局正因科学、监管和商业策略的融合变革而重塑，这些变革共同改变了竞争动态和推广途径。微生物基因组学、精准製剂和递送技术的进步提高了生物防治剂的一致性和靶向性，从而缩小了生物防治剂与传统化学农药之间的认知差距。此外，昆虫学家、微生物学家和製剂科学家之间的跨学科合作正在开发出结合互补作用机制并简化施用物流的综合产品。

本分析探讨了近期关税变化如何重塑生物防治利害关係人的采购经济、供应链韧性和策略製造决策。

近期实施的关税措施和贸易政策调整（预计在2025年前后生效）正对全球农业投入价值链产生累积压力，尤其对生物防治产品造成衝击，因为其价值依赖于专用原材料、精密製造工艺和跨境分销。某些农产品和成品关税的提高推高了依赖海外供应链产品的接收成本，促使製造商重新评估筹资策略并评估其庞大供应商网路的韧性。在某些情况下，关税带来的成本压力正在加速企业将生产转移回国内和区域化，以降低贸易波动带来的风险。

将产品类型、作物应用、配方、应用方法、最终用户画像和分销管道与商业化策略联繫起来的综合細項分析。

精细化的市场细分观点对于使产品开发和市场进入策略与终端用户在不同作物、配方和应用方法方面的需求相匹配至关重要。产品类型细分包括生物化学品（如信息素和植物萃取物）、大型生物（如线虫、寄生性天敌和捕食性昆虫）以及微生物製剂（由细菌、真菌和病毒组成），每种产品都有其独特的功效、储存要求和监管要求。作物类型细分涵盖谷物、水果和蔬菜、油籽和豆类以及草坪和观赏植物，普通作物和特种作物在病虫害危害、收穫时间和残留限量方面存在显着差异。

美洲、欧洲、中东和非洲以及亚太地区的区域差异和营运要求影响实施、监管策略和分销模式。

区域趋势对生物防治的研发、引进和商业化具有决定性影响，每个地理丛集都有其独特的管理体制、气候条件和分销基础设施。在美洲，多样化的生产体系和零售商先进的永续性措施为生物防治解决方案创造了有利环境，但国家和地方政府层面的复杂法规要求采取个人化的註册和合规方法。在欧洲、中东和非洲，法律规范往往侧重于环境安全和可追溯性，市场准入通常取决于是否符合严格的田间试验数据和认证体系，而全部区域气候和物流的多样性则要求对产品进行区域性调整。

生物防治生态系中创新者、产品组合扩展公司和区域製造商之间的竞争定位和能力建构优先事项。

生物防治领域的竞争动态由三类企业共同塑造：高度专业化的创新企业、不断拓展产品线的成熟农资企业以及专注于本地生产的区域性製造商。主要企业强调严格的田间检验、可扩展的生产流程以及将产品供应与技术咨询支援相结合的综合服务。投资重点集中在配方科学（以提高稳定性）、精准喷洒技术（以提高防治效果）以及品质保证系统（以确保批次间一致性）。

为领导者提供的实用策略指南，重点在于现场检验、配方创新、本地生产和综合服务模式，以加速推广应用。

产业领导企业应采取协作策略，平衡短期商业化与长期能力建设，以实现价值最大化并加速产品推广应用。首先，投资稳健的田间检验项目，以在不同的农业生态区域和种植系统中产生可重复的功效数据。优先考虑的证据能够减少推广应用的障碍，并有助于获得监管部门的核准。其次，开发配方和应用方法的创新，以延长产品保质期并提高易用性，从而减少经销商和生产商面临的物流限制。第三，推广本地化生产或策略性合约生产，以降低贸易风险并缩短生技药品供应链的时间限制。

调查方法结合了对专家的直接访谈、同行评审的证据、监管文件审查和供应链分析，以得出可操作的策略见解。

本研究结合对技术专家、供应链负责人和政策顾问的访谈，以及对同行评审文献、已发布的监管文件和原始田间试验总结的系统性回顾，建构了生物防治技术应用趋势的全面观点。研究还从多个种植系统和地区的实践者收集了定性数据，以反映实际应用和限制。这些研究结果与实验室和田间功效报告进行了交叉比对，以确保观察结果与报告指标的一致性。

整合科学进步、监管趋势和商业性需求，为生物防治解决方案的可持续扩展制定切实可行的路径。

科学、监管和商业性证据的整合表明，生物防治剂已不再是边缘选项，而是韧性作物保护策略的核心组成部分，这标誌着一个转折点的到来。技术进步和配方改进正在缩小性能差距，新的法规和商业模式正在降低推广应用的门槛。同时，关税趋势和供应链风险凸显了生产柔软性和区域生产能力对于维持供应连续性的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：生物防治剂市场：依产品类型划分

  • 生化物质
    • 信息素
    • 植物萃取物
  • 大型生物
    • 线虫
    • 寄生天敌
    • 捕食性昆虫
  • 微生物製剂
    • 细菌
    • 真菌
    • 病毒

第九章：生物防治剂市场：依作物类型划分

  • 粮食
  • 水果和蔬菜
  • 油籽和豆类
  • 草坪和观赏植物

第十章：以剂型分類的生物防治剂市场

  • 颗粒
  • 液体
  • 可湿性粉

第十一章：以施用方法分類的生物防治剂市场

  • 叶面喷布
  • 后处理
  • 种子处理
  • 土壤处理

第十二章：生物防治市场：依通路划分

  • 直销
  • 批发商和零售商
  • 线上管道

第十三章：生物害虫防治市场：依最终用户划分

  • 商业农业
  • 温室
  • 家居与园艺
  • 园艺

第十四章：生物防治市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：生物防治剂市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：生物防治剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国生物医学控制市场

第十八章：中国生物防治市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Anatis Bioprotection Ltd.
  • Andermatt Biocontrol AG
  • Arbico Organics, Inc.
  • BASF SE
  • Bayer AG
  • BioBee Sde Eliyahu Ltd.
  • Biobest Group NV
  • Bioceres Crop Solutions Corp.
  • BioFirst Group, Inc.
  • Bioline AgroSciences Ltd.
  • BioWorks, Inc.
  • CBC
  • Certis Biologicals BV
  • FMC Corporation
  • Isagro SpA
  • Koppert Biological Systems BV
  • Marrone Bio Innovations, Inc.
  • Natural Insect Control, Inc.
  • Novozymes A/S
  • Nufarm Limited
  • Sumitomo Chemical Co., Ltd.
  • Syngenta Group AG
  • UPL Corporation Limited
  • Valent BioSciences LLC
Product Code: MRR-5C6F41F5AF8C

The Biological Control Agents Market was valued at USD 6.12 billion in 2025 and is projected to grow to USD 6.59 billion in 2026, with a CAGR of 7.74%, reaching USD 10.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.12 billion
Estimated Year [2026] USD 6.59 billion
Forecast Year [2032] USD 10.32 billion
CAGR (%) 7.74%

Contextual framing of biological control adoption that clarifies regulatory, agronomic, and commercial drivers shaping strategic decisions across crop protection portfolios

The agricultural landscape is undergoing a foundational shift as stakeholders seek sustainable, biologically based alternatives to conventional chemical controls. Increasing regulatory scrutiny on synthetic pesticides, heightened consumer demand for residue-free produce, and the intensifying need for resilient supply chains have converged to elevate biological control agents from niche innovation to strategic priority. This introduction establishes the context for understanding how biologicals-ranging from pheromones and plant extracts to living macroorganisms and microbial agents-fit into broader crop protection portfolios and influence long-term agronomic strategies.

Adoption is being driven by practical imperatives as much as by values. Growers face mounting pressure to reduce input risk, meet retailer specifications, and conform to evolving certification standards. In response, product developers and distributors are refining formulations, application modes, and delivery systems to enhance consistency, shelf life, and field performance. Simultaneously, investment in R&D and localized manufacturing is accelerating to address variability across climates and cropping systems. The net effect is a maturing ecosystem where biology-led tools are increasingly integrated into integrated pest management plans rather than being positioned as last-resort options.

This framing sets the stage for deeper analysis of technological breakthroughs, regulatory developments, and commercial dynamics that together shape the trajectory of biological control adoption. Understanding these drivers and constraints is essential for executives and technical leaders formulating strategies to scale efficacy, manage risk, and capture value from next-generation crop protection solutions.

How scientific advances, regulatory refinement, and evolving commercial channels are converging to transform adoption pathways and competitive dynamics in biological control

The landscape for biological control agents is being reshaped by convergent shifts in science, regulation, and commercial strategy that collectively alter competitive dynamics and adoption pathways. Advances in microbial genomics, precision formulation, and delivery technologies are improving consistency and targeting, which in turn reduces the perception gap between biologicals and conventional chemistries. Moreover, cross-disciplinary collaborations between entomologists, microbiologists, and formulation scientists are producing integrated products that combine complementary modes of action while streamlining application logistics.

On the regulatory front, agencies are refining pathways to evaluate efficacy and environmental safety, and private standards are raising the bar for residue and sustainability credentials. These developments favor suppliers who can demonstrate robust field data and transparent production practices. In parallel, commercial channels are evolving: digital agronomy platforms and data-driven advisory services are enabling targeted recommendations, while upstream supply chain actors are investing in storage and cold-chain solutions to maintain viability of living products. As a result, market participants are shifting from transactional sales models toward partnership-based engagement that emphasizes on-farm performance and lifecycle support.

Together, these transformative shifts are lowering technical and commercial barriers to adoption, accelerating integration of biological control agents into mainstream crop protection strategies, and prompting incumbents and new entrants alike to reorient their R&D and go-to-market approaches toward resilience, traceability, and demonstrable field outcomes.

Analyzing how recent tariff shifts have reshaped sourcing economics, supply chain resilience, and strategic manufacturing decisions for biological control stakeholders

Recent tariff actions and trade policy shifts introduced in and around 2025 have exerted cumulative pressure across global agricultural input supply chains, with particular implications for biological control agents whose value depends on specialized raw materials, manufacturing precision, and cross-border distribution. Increased duties on certain inputs and finished goods have raised landed costs for products that rely on immigrant supply chains, prompting manufacturers to reassess sourcing strategies and to evaluate the resilience of extended supplier networks. In some cases, tariff-induced cost pressure has accelerated onshoring initiatives and closer regionalization of production to reduce exposure to trade volatility.

These trade measures have also affected the logistics and inventory calculus for distributors and growers. Higher import costs combined with uncertainty over tariff permanence have encouraged larger safety stocks of viable biological products and greater demand for domestically produced alternatives. At the same time, supply chain participants have faced higher working capital requirements and greater complexity in compliance, including additional documentation and customs processes that can impact shelf life-sensitive agents. Consequently, companies with vertically integrated capabilities or diversified sourcing options have found it easier to absorb or mitigate tariff-related disruptions.

Importantly, tariff dynamics have prompted strategic re-evaluation rather than universal contraction. Many firms have accelerated investments in local manufacturing scale-up, technology transfer partnerships, and licensing agreements to preserve market access and control cost trajectories. Policymakers, procurement teams, and industry leaders must now balance short-term cost impacts against longer-term benefits of supply chain resilience, nearshoring, and strategic inventory management to maintain continuity of biological control deployment across diverse cropping systems.

Integrated segmentation analysis that links product types, crop applications, formulations, application modes, end-user profiles, and distribution channels to commercialization strategy

A nuanced segmentation perspective is essential to align product development and go-to-market strategies with end-user needs across crops, formulations, and application modes. Product type differentiation encompasses biochemicals such as pheromones and plant extracts, macroorganisms including nematodes, parasitoids, and predatory insects, and microbial agents comprising bacteria, fungi, and viruses, each with distinct efficacy profiles, storage requirements, and regulatory considerations. Crop type segmentation spans cereals and grains, fruits and vegetables, oilseeds and pulses, and turf and ornamentals, with pest pressure, harvest windows, and tolerance for residue varying substantially between commodity and specialty crops.

Formulation choices-granules, liquid, and wettable powders-drive logistics, shelf life, and ease of integration into existing spray or soil treatment systems, while modes of application such as foliar application, post-harvest application, seed treatment, and soil treatment determine compatibility with farm equipment and labor practices. End-user categories range from commercial agriculture and greenhouses to home and garden and horticulture, each demanding different service models, technical support, and packaging sizes. Distribution channels including direct sales, distributors and retailers, and online channels influence margin structures, after-sales service expectations, and adoption velocity.

Taken together, these segmentation dimensions inform product roadmaps, regulatory strategies, and channel investments. A coordinated approach that maps product attributes to crop-specific pest challenges and end-user operational realities increases the probability of successful commercialization and long-term uptake.

Regional differentiation and operational imperatives that shape adoption, regulatory strategy, and distribution models across the Americas, Europe Middle East Africa, and Asia Pacific

Regional dynamics exert a defining influence on biological control development, adoption, and commercialization, with each geographic cluster presenting distinct regulatory regimes, climatic conditions, and distribution infrastructures. In the Americas, diverse production systems and progressive sustainability commitments among retailers have created fertile ground for biological solutions, though regulatory complexity across national and subnational jurisdictions requires tailored registration and compliance approaches. In Europe, Middle East & Africa, regulatory frameworks tend to emphasize environmental safety and traceability, and market access often depends on rigorous field trial data and alignment with certification schemes, while climatic and logistical heterogeneity across the region necessitate region-specific product adaptations.

The Asia-Pacific region is characterized by rapidly modernizing agricultural systems, intense pest pressures in many subtropical cropping zones, and growing demand for reduced-residue practices. Here, the speed of adoption is influenced by farmer economics, distribution density, and the availability of local technical advisory services. Across all regions, the capacity to maintain product viability through cold-chain and storage solutions, to provide on-the-ground technical support, and to navigate local regulatory pathways is a decisive factor. Regional partnerships, contract manufacturing arrangements, and targeted field demonstration programs often prove more effective than one-size-fits-all commercial models.

Understanding these regional nuances enables companies to prioritize investments, structure regulatory dossiers, and design deployment strategies that respect local agronomic realities while leveraging global science and supply capabilities to scale impact.

Competitive positioning and capability-building priorities that distinguish innovators, portfolio expanders, and regional manufacturers in the biological control ecosystem

Competitive dynamics in the biological control space are shaped by a mix of specialized innovators, agri-input incumbents expanding their portfolios, and regional manufacturers focused on localized production. Leading firms emphasize rigorous field validation, scalable production processes, and integrated service offerings that combine product supply with technical advisory support. Investment priorities are concentrated on formulation science to improve stability, precision application technology to enhance efficacy, and quality assurance systems to ensure consistency across batches.

Strategic partnerships, licensing arrangements, and acquisitions are common as companies seek to close capability gaps, access new crops or geographies, and accelerate time-to-market for promising candidates. Equally important is the development of distribution networks that can handle biologically sensitive goods, including cold-chain logistics and specialized retailer education. Firms that succeed typically integrate a strong R&D backbone with market-facing teams capable of translating trial data into practical agronomic recommendations and commercial programs tuned to local grower needs.

Intellectual property, regulatory dossiers, and validated field protocols represent competitive moats that support premium positioning. At the same time, collaborative research consortia and public-private partnerships are expanding the evidence base for biological controls, enabling broader acceptance and faster integration into integrated pest management systems. For commercial leaders, the path forward combines scientific rigor, operational excellence, and customer-centric service models.

Actionable strategic playbook for leaders centered on field validation, formulation innovation, regional production, and integrated service models to accelerate adoption

Industry leaders should pursue a coordinated strategy that balances near-term commercialization with long-term capability building to capture value and accelerate adoption. First, invest in robust field validation programs that generate reproducible efficacy data across diverse agroecological zones and cropping systems; prioritized evidence reduces adoption friction and supports regulatory acceptance. Second, develop formulation and delivery innovations to improve product shelf life and ease of use, thereby reducing logistical constraints for distributors and growers. Third, pursue regional manufacturing or strategic contract production to mitigate trade-related exposure and to shorten supply chains for time-sensitive biologicals.

In parallel, cultivate integrated service models that combine product supply with digital advisory tools, extension services, and training programs to maximize on-farm performance. Forge strategic partnerships with input distributors, research institutions, and local agronomy networks to accelerate market penetration in priority geographies. Additionally, align regulatory engagement with transparent quality controls and environmental safety data to streamline registration pathways and to reassure procurement stakeholders. Finally, adopt flexible commercial terms and packaging options to address the distinct needs of commercial agriculture, greenhouse operations, and home gardeners, while investing in education that demonstrates return-on-practice rather than relying solely on product claims.

By implementing these actions, companies can reduce adoption barriers, strengthen stakeholder trust, and create scalable pathways for biological control agents to complement and, where appropriate, replace conventional interventions.

Methodological approach combining primary expert interviews, peer-reviewed evidence, regulatory dossier reviews, and supply chain analysis to derive practical strategic insights

This research synthesizes primary interviews with technical experts, supply chain leaders, and policy advisors together with a structured review of peer-reviewed literature, public regulatory filings, and proprietary field trial summaries to build a comprehensive perspective on biological control adoption dynamics. Primary qualitative inputs were collected from practitioners across multiple crop systems and geographies to capture operational realities and adoption constraints. These insights were triangulated with laboratory and field efficacy reports to ensure coherence between observed outcomes and reported metrics.

Analytical methods emphasized comparative evaluation across product types, formulation classes, and application modes, while paying particular attention to regional regulatory pathways and distribution capabilities. Supply chain analyses incorporated logistics constraints, manufacturing lead-times, and sensitivity to trade policy shifts. Where available, longitudinal field trial data were reviewed to assess repeatability and robustness under varying climatic and agronomic conditions. The methodology prioritizes transparency in data provenance, replicability in comparative assessments, and practical relevance for decision-makers responsible for R&D prioritization, regulatory planning, and commercialization strategy.

Limitations of the methodology include variability in publicly available field data and differences in trial design across regions; therefore, conclusions emphasize patterns and strategic implications rather than single-study extrapolations. The approach nonetheless provides a defensible foundation for executives to inform investment choices and operational planning.

Synthesis of scientific advancements, regulatory trends, and commercial imperatives that define a pragmatic route for scaling biological control solutions sustainably

The synthesis of scientific, regulatory, and commercial evidence points to an inflection where biological control agents become central components of resilient crop protection strategies rather than peripheral options. Technological advancements and formulation improvements have narrowed performance gaps, while new regulatory and commercial models are reducing barriers to deployment. At the same time, tariff dynamics and supply chain risks underscore the importance of manufacturing flexibility and regional production capabilities to preserve continuity of supply.

Strategic success will hinge on the ability of companies to connect rigorous efficacy data with operationalized delivery systems and to provide service models that translate product attributes into reliable on-farm outcomes. Collaboration across stakeholders-suppliers, distributors, researchers, and policymakers-will be key to harmonizing standards, accelerating registration processes, and building grower confidence. In short, biological control agents present a pragmatic pathway to more sustainable pest management, but their widescale impact depends on coordinated investment in science, logistics, and market development.

Executives and technical leaders should therefore prioritize integrated strategies that address evidence generation, regulatory alignment, and supply chain resilience, enabling biological solutions to scale in ways that are economically viable, environmentally responsible, and operationally practical.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Control Agents Market, by Product Type

  • 8.1. Biochemicals
    • 8.1.1. Pheromones
    • 8.1.2. Plant Extracts
  • 8.2. Macroorganisms
    • 8.2.1. Nematodes
    • 8.2.2. Parasitoids
    • 8.2.3. Predatory Insects
  • 8.3. Microbial Agents
    • 8.3.1. Bacteria
    • 8.3.2. Fungi
    • 8.3.3. Viruses

9. Biological Control Agents Market, by Crop Type

  • 9.1. Cereals And Grains
  • 9.2. Fruits And Vegetables
  • 9.3. Oilseeds And Pulses
  • 9.4. Turf And Ornamentals

10. Biological Control Agents Market, by Formulation

  • 10.1. Granules
  • 10.2. Liquid
  • 10.3. Wettable Powders

11. Biological Control Agents Market, by Mode Of Application

  • 11.1. Foliar Application
  • 11.2. Post-Harvest Application
  • 11.3. Seed Treatment
  • 11.4. Soil Treatment

12. Biological Control Agents Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors And Retailers
  • 12.3. Online Channels

13. Biological Control Agents Market, by End User

  • 13.1. Commercial Agriculture
  • 13.2. Greenhouses
  • 13.3. Home And Garden
  • 13.4. Horticulture

14. Biological Control Agents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Biological Control Agents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Biological Control Agents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Biological Control Agents Market

18. China Biological Control Agents Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Anatis Bioprotection Ltd.
  • 19.6. Andermatt Biocontrol AG
  • 19.7. Arbico Organics, Inc.
  • 19.8. BASF SE
  • 19.9. Bayer AG
  • 19.10. BioBee Sde Eliyahu Ltd.
  • 19.11. Biobest Group N.V.
  • 19.12. Bioceres Crop Solutions Corp.
  • 19.13. BioFirst Group, Inc.
  • 19.14. Bioline AgroSciences Ltd.
  • 19.15. BioWorks, Inc.
  • 19.16. CBC
  • 19.17. Certis Biologicals B.V.
  • 19.18. FMC Corporation
  • 19.19. Isagro S.p.A.
  • 19.20. Koppert Biological Systems B.V.
  • 19.21. Marrone Bio Innovations, Inc.
  • 19.22. Natural Insect Control, Inc.
  • 19.23. Novozymes A/S
  • 19.24. Nufarm Limited
  • 19.25. Sumitomo Chemical Co., Ltd.
  • 19.26. Syngenta Group AG
  • 19.27. UPL Corporation Limited
  • 19.28. Valent BioSciences LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PHEROMONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PHEROMONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PHEROMONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PLANT EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PLANT EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PLANT EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY NEMATODES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY NEMATODES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY NEMATODES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PARASITOIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PARASITOIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PARASITOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PREDATORY INSECTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PREDATORY INSECTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PREDATORY INSECTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY VIRUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CEREALS AND GRAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CEREALS AND GRAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CEREALS AND GRAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FRUITS AND VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FRUITS AND VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FRUITS AND VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY OILSEEDS AND PULSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY OILSEEDS AND PULSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY OILSEEDS AND PULSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY TURF AND ORNAMENTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY TURF AND ORNAMENTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY TURF AND ORNAMENTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY WETTABLE POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY WETTABLE POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY WETTABLE POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FOLIAR APPLICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FOLIAR APPLICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FOLIAR APPLICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY POST-HARVEST APPLICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY POST-HARVEST APPLICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY POST-HARVEST APPLICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTORS AND RETAILERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COMMERCIAL AGRICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GREENHOUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GREENHOUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GREENHOUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HOME AND GARDEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HOME AND GARDEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HOME AND GARDEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HORTICULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HORTICULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY HORTICULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 193. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 197. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. GCC BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 223. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 227. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. G7 BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 234. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 237. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. NATO BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY BIOCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MACROORGANISMS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MICROBIAL AGENTS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA BIOLOGICAL CONTROL AGENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)